Paratek Pharmaceuticals, Inc.
SUBSTITUTED TETRACYCLINE COMPOUNDS
Last updated:
Abstract:
The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms.
Status:
Application
Type:
Utility
Filling date:
4 Jan 2021
Issue date:
23 Dec 2021